https://endpts.com/inside-the-race-to-make-psychedelics-mainstream-medicines/
Read More
https://www.benzinga.com/markets/cannabis/22/03/26284541/five-companies-developing-second-generation-psychedelics-for-mental-health
Read More
Patent Applications Aim to Expand Opportunities for Novel Therapeutics to Address a Broad Range of Psychiatric and Neurological Disorders NAPLES, Fla., March 15, 2022 /CNW/ – Enveric Biosciences Inc. (NASDAQ: ENVB) (“Enveric” or…
Read More
NAPLES, Fla., March 3, 2022 /CNW/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a cutting-edge neuroscience company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of…
Read More
Robust Portfolio of Psychedelic-Inspired Molecules Positions Enveric to Achieve Global Patent Protection to potentially Cover Millions of Novel Pharmaceutical Candidates NAPLES, Fla., March 1, 2022 — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),…
Read More
https://psychedelichealth.co.uk/2022/02/21/trial-psychedelic-therapy-cancer-distress/
Read More
Clinical trial aim is to include the identification and characterization of the Cancer Related Distress symptoms most responsive to psychedelic-associated therapy NAPLES, Fla., Feb. 17, 2022 /CNW/ – Enveric Biosciences (NASDAQ: ENVB)(“Enveric” or…
Read More
https://www.benzinga.com/markets/cannabis/22/02/25697576/psilocybin-for-cancer-related-distress-enveric-to-launch-clinical-trial-in-partnership-with-univ
Read More
https://edmontonjournal.com/cannabis-health/ucalgary-to-collaborate-on-clinical-trial-assessing-psychedelic-treatments-and-cancer-related-distress
Read More
NAPLES, Fla., Feb. 15, 2022 /CNW/ – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience company developing next-generation, psychedelic-inspired mental health and oncology treatments, today announced the closing of its…
Read More
